Short Interest in Cyanotech Co. (OTCMKTS:CYAN) Declines By 85.0%

Cyanotech Co. (OTCMKTS:CYAN) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 653 shares, a decrease of 85.0% from the August 15th total of 4,353 shares. Based on an average daily trading volume, of 14,470 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Cyanotech Stock Down 4.4%

Shares of Cyanotech stock traded down $0.02 during trading hours on Friday, reaching $0.49. The company’s stock had a trading volume of 2,000 shares, compared to its average volume of 4,995. Cyanotech has a one year low of $0.23 and a one year high of $0.57. The company has a market capitalization of $3.52 million, a P/E ratio of -1.94 and a beta of 0.07. The stock’s fifty day simple moving average is $0.50 and its two-hundred day simple moving average is $0.44. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.39 and a current ratio of 1.06.

Cyanotech (OTCMKTS:CYAN) last posted its earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share for the quarter. Cyanotech had a negative net margin of 0.25% and a negative return on equity of 0.86%.

Cyanotech Company Profile

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.